List of Morphotek, Inc. patents

Patents where

Current Assignee

Name

‌

Morphotek, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7592426 Anti-mesothelin antibodies	Patent 7592426 was granted and assigned to Morphotek, Inc. on September, 2009 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	7592426	September 22, 2009
‌ US Patent 8206710 Anti-mesothelin antibodies	Patent 8206710 was granted and assigned to Morphotek, Inc. on June, 2012 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	8206710	June 26, 2012
‌ US Patent 8481703 Anti-mesothelin antibodies	Patent 8481703 was granted and assigned to Morphotek, Inc. on July, 2013 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	8481703	July 9, 2013
‌ US Patent 9115197 Anti-mesothelin antibodies	Patent 9115197 was granted and assigned to Morphotek, Inc. on August, 2015 by the United States Patent and Trademark Office.	‌ Morphotek, Inc.	‌ Morphotek, Inc.	United States Patent and Trademark Office	9115197	August 25, 2015
‌ US Patent 7235643 Antibodies and methods for generating genetically altered antibodies with high affinity	Patent 7235643 was granted and assigned to Morphotek, Inc. on June, 2007 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	7235643	June 26, 2007
‌ US Patent 7615372 Antibodies with immune effector activity and that internalize in endosialin-positive cells	Patent 7615372 was granted and assigned to Morphotek, Inc. on November, 2009 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	7615372	November 10, 2009
‌ US Patent 8124083 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells	Patent 8124083 was granted and assigned to Morphotek, Inc. on February, 2012 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	8124083	February 28, 2012
‌ US Patent 8470607 Inhibition of angiogenesis	Patent 8470607 was granted and assigned to Morphotek, Inc. on June, 2013 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	8470607	June 25, 2013
‌ US Patent 7223598 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells	Patent 7223598 was granted and assigned to Morphotek, Inc. on May, 2007 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	7223598	May 29, 2007
‌ US Patent 8227439 Treatment of metastatic tumors	Patent 8227439 was granted and assigned to Morphotek, Inc. on July, 2012 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	8227439	July 24, 2012
‌ US Patent 9018347 Chlorotoxin polypeptides and conjugates and uses thereof	Patent 9018347 was granted and assigned to Morphotek, Inc. on April, 2015 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	9018347	April 28, 2015
‌ US Patent 9422367 Antigenic GM-CSF peptides and antibodies to GM-CSF	Patent 9422367 was granted and assigned to Morphotek, Inc. on August, 2016 by the United States Patent and Trademark Office.	‌ Morphotek, Inc.	‌ Morphotek, Inc.	United States Patent and Trademark Office	9422367	August 23, 2016
‌ US Patent 9505842 Methods for inhibiting the binding of endosialin to ligands	Patent 9505842 was granted and assigned to Morphotek, Inc. on November, 2016 by the United States Patent and Trademark Office.	‌ Morphotek, Inc.	‌ Morphotek, Inc.	United States Patent and Trademark Office	9505842	November 29, 2016
‌ US Patent 8623364 Antigenic GM-CSF peptides and antibodies to GM-CSF	Patent 8623364 was granted and assigned to Morphotek, Inc. on January, 2014 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	8623364	January 7, 2014
‌ US Patent 9359428 High affinity antibodies that neutralize	Patent 9359428 was granted and assigned to Morphotek, Inc. on June, 2016 by the United States Patent and Trademark Office.	‌ Morphotek, Inc.	‌ Morphotek, Inc.	United States Patent and Trademark Office	9359428	June 7, 2016
‌ US Patent 9603952 Treatment of metastatic tumors	Patent 9603952 was granted and assigned to Morphotek, Inc. on March, 2017 by the United States Patent and Trademark Office.	‌ Morphotek, Inc.	‌ Morphotek, Inc.	United States Patent and Trademark Office	9603952	March 28, 2017
‌ US Patent 9023595 Treatment of metastatic tumors	Patent 9023595 was granted and assigned to Morphotek, Inc. on May, 2015 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	9023595	May 5, 2015
‌ US Patent 9868780 High affinity antibodies that neutralize	Patent 9868780 was granted and assigned to Morphotek, Inc. on January, 2018 by the United States Patent and Trademark Office.	‌ Morphotek, Inc.	‌ Morphotek, Inc.	United States Patent and Trademark Office	9868780	January 16, 2018
‌ US Patent 7754450 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization	Patent 7754450 was granted and assigned to Morphotek, Inc. on July, 2010 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	7754450	July 13, 2010
‌ US Patent 7807416 Antibodies and methods for generating genetically altered antibodies with enhanced effector function	Patent 7807416 was granted and assigned to Morphotek, Inc. on October, 2010 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	7807416	October 5, 2010
‌ US Patent 9234015 Chlorotoxin polypeptides and conjugates and uses thereof	Patent 9234015 was granted and assigned to Morphotek, Inc. on January, 2016 by the United States Patent and Trademark Office.	‌ Morphotek, Inc.	‌ Morphotek, Inc.	United States Patent and Trademark Office	9234015	January 12, 2016
‌ US Patent 7671179 Antibodies and methods for generating genetically altered antibodies with high affinity	Patent 7671179 was granted and assigned to Morphotek, Inc. on March, 2010 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	7671179	March 2, 2010
‌ US Patent 9512223 Methods for treatment of gastric cancer	Patent 9512223 was granted and assigned to Morphotek, Inc. on December, 2016 by the United States Patent and Trademark Office.	‌ Morphotek, Inc.	‌ Morphotek, Inc.	United States Patent and Trademark Office	9512223	December 6, 2016
‌ US Patent 8389691 Antibodies with immune effector activity and that internalize in endosialin-positive cells	Patent 8389691 was granted and assigned to Morphotek, Inc. on March, 2013 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	8389691	March 5, 2013
‌ US Patent 8105836 Chemical inhibitors of mismatch repair	Patent 8105836 was granted and assigned to Morphotek, Inc. on January, 2012 by the United States Patent and Trademark Office.		‌ Morphotek, Inc.	United States Patent and Trademark Office	8105836	January 31, 2012

Results per page:

54 results

0 selected

54 results

0 selected